Key Learnings While Forging A Partnership In Unprecedented Times

By John Orwin

During my more than 25 years in this industry, I’ve seen how increased collaboration between life sciences organizations has helped accelerate the development and delivery of countless innovative treatments to patients in need. Partnerships between pharmaceutical companies and biotech companies, as well as academic institutions and government organizations, have been essential to overcoming complex scientific and technological challenges, gaining operational efficiencies, expanding capabilities, and securing early access to novel biomarkers and targets.